IL22 and neoplasm: The IL-22 expression in tumors was a poor prognostic factor for OS, and along with tumor-IL-22R1, was positively associated with the infiltration of CD68-positive TAM, which together displayed the worst prognosis outcomes regarding both OS and RFS [97].